Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Hold
8,837
0.39% 36
2026
Q1
$1.06M Sell
8,837
-460
-5% -$53.1K 0.42% 36
2025
Q4
$979K Hold
9,297
0.41% 36
2025
Q3
$780K Hold
9,297
0.35% 39
2025
Q2
$736K Sell
9,297
-4,675
-33% -$372K 0.35% 38
2025
Q1
$1.25M Sell
13,972
-602
-4% -$56.2K 0.66% 26
2024
Q4
$1.45M Hold
14,574
0.78% 26
2024
Q3
$1.66M Sell
14,574
-213
-1% -$25.3K 0.89% 23
2024
Q2
$1.83M Sell
14,787
-391
-3% -$50.4K 1.04% 19
2024
Q1
$2M Buy
15,178
+11
+0.1% +$1.36K 1.14% 18
2023
Q4
$1.65M Buy
15,167
+76
+0.5% +$7.89K 1.02% 21
2023
Q3
$1.55M Buy
15,091
+50
+0.3% +$5.39K 1.12% 17
2023
Q2
$1.74M Hold
15,041
1.24% 17
2023
Q1
$1.6M Buy
+15,041
New +$1.62M 1.21% 18
2022
Q1
Sell
-300
Closed -$23K 136
2021
Q4
$23K Buy
+300
New +$23.9K 0.02% 97

Other funds holding MRK

Shore Point Advisors's MRK Position: Q2 2026 in Review

Shore Point Advisors held its Merck (MRK) position steady in Q2 2026 at 8,837 shares worth $1.14M. The position accounts for 0.39% of the portfolio, ranked #36.

Shore Point Advisors first reported a position in MRK in Q4 2021 and has held it in 15 quarters since. The position peaked at $2M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Shore Point Advisors held 8,837 shares of Merck worth $1.14M as of Q2 2026.
  • Shore Point Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.39% of Shore Point Advisors's portfolio in Q2 2026, its #36 holding.
  • Shore Point Advisors first reported a position in Merck in Q4 2021 and has held it in 15 quarters since.
  • Shore Point Advisors's Merck position peaked at $2M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Shore Point Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.